Pfizer Inc (PFE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2013 | 12-2012 | 12-2011 | 12-2010 | 12-2009 | |
| Sales | 51,584,000 | 54,657,000 | 61,035,000 | 65,165,000 | 49,269,000 |
| Cost of Goods | 9,586,000 | 9,821,000 | 12,500,000 | 14,788,000 | 8,459,000 |
| Gross Profit | 41,998,000 | 44,836,000 | 48,535,000 | 50,377,000 | 40,810,000 |
| Operating Expenses | 26,814,000 | 29,572,000 | 34,568,000 | 36,965,000 | 29,851,000 |
| Operating Income | 15,184,000 | 15,264,000 | 13,967,000 | 13,412,000 | 10,959,000 |
| Other Income | 532,000 | -4,022,000 | -2,486,000 | -3,941,000 | -285,000 |
| Pre-tax Income | 15,716,000 | 11,242,000 | 11,481,000 | 9,471,000 | 10,674,000 |
| Income Tax | 4,306,000 | 2,221,000 | 3,621,000 | 1,153,000 | 2,145,000 |
| Net Income Continuous | 11,410,000 | 9,021,000 | 7,860,000 | 8,318,000 | 8,529,000 |
| Net Income Discontinuous | 10,662,000 | 5,577,000 | 2,189,000 | -30,000 | 114,000 |
| Minority Interests | 69,000 | 28,000 | 40,000 | 31,000 | 8,000 |
| Net Income | $22,003,000 | $14,570,000 | $10,009,000 | $8,257,000 | $8,635,000 |
| EPS Basic Total Ops | 3.23 | 1.96 | 1.28 | 1.03 | 1.23 |
| EPS Basic Continuous Ops | 1.67 | 1.21 | 1.00 | 1.03 | 1.22 |
| EPS Basic Discontinuous Ops | 1.56 | 0.75 | 0.28 | 0.00 | 0.02 |
| EPS Diluted Total Ops | 3.19 | 1.94 | 1.27 | 1.02 | 1.23 |
| EPS Diluted Continuous Ops | 1.65 | 1.20 | 0.99 | 1.03 | 1.21 |
| EPS Diluted Discontinuous Ops | 1.54 | 0.74 | 0.28 | 0.00 | 0.02 |
| EBITDA(a) | $21,594,000 | $22,919,000 | $22,993,000 | $21,811,000 | $15,716,000 |